SuperworthAEON Biopharma shares outstanding AEON
Diluted shares outstanding, averaged over each quarter, from 2021.
- Latest quarter, to Jun 30, 2026
- 50.5M
- On a year earlier
- +355.6%
- more shares
AEON Biopharma had 50.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 355.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 12.9M | +2113% |
| FY2024 | 581.1K | −70% |
| FY2022 | 1.9M | +403% |
| FY2021 | 383.3K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 50.5M | +356% | |
| Q1 FY26 | 40.6M | +919% | |
| Q4 FY25 | 12.9M | +2113% | |
| Q3 FY25 | 11.6M | +2019% | |
| Q2 FY25 | 11.1M | +1954% | |
| Q1 FY25 | 4M | +669% | |
| Q4 FY24 | 581.1K | n/a | |
| Q3 FY24 | 549.2K | n/a | |
| Q2 FY24 | 539.8K | −72% | |
| Q1 FY24 | 517.9K | −73% | |
| Q2 FY23 | 1.9M | +403% | |
| Q1 FY23 | 1.9M | +403% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on AEON Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.